Respiri Limited (AU:RSH) has released an update.
Respiri Limited has announced a significant partnership with Ceras to provide remote patient services, securing an initial contract with Covenant Health Inc. worth approximately A$1.1M for 750+ patients, with the potential for substantial growth. This collaboration, blending Respiri’s clinical expertise with Ceras’s AI technology, is expected to propel the company towards monthly profitability by the end of 2024 and enhance patient care.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
